These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 7545159

  • 1. Risperidone in the treatment of affective illness and obsessive-compulsive disorder.
    Jacobsen FM.
    J Clin Psychiatry; 1995 Sep; 56(9):423-9. PubMed ID: 7545159
    [Abstract] [Full Text] [Related]

  • 2. Low-dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome.
    Jacobsen FM.
    J Clin Psychiatry; 1993 Jun; 54(6):229-34. PubMed ID: 8331092
    [Abstract] [Full Text] [Related]

  • 3. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
    Keck PE, Wilson DR, Strakowski SM, McElroy SL, Kizer DL, Balistreri TM, Holtman HM, DePriest M.
    J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
    [Abstract] [Full Text] [Related]

  • 4. Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome.
    Perugi G, Toni C, Frare F, Travierso MC, Hantouche E, Akiskal HS.
    J Clin Psychiatry; 2002 Dec; 63(12):1129-34. PubMed ID: 12523872
    [Abstract] [Full Text] [Related]

  • 5. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G, Fleischhacker W, Arango C, Baumann P, Davidson M, de Hert M, Falkai P, Kapur S, Leucht S, Licht R, Naber D, O'Keane V, Papakostas G, Vieta E, Zohar J.
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [Abstract] [Full Text] [Related]

  • 6. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
    Erzegovesi S, Guglielmo E, Siliprandi F, Bellodi L.
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
    [Abstract] [Full Text] [Related]

  • 7. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study.
    Vieta E, Goikolea JM, Corbella B, Benabarre A, Reinares M, Martínez G, Fernández A, Colom F, Martínez-Arán A, Torrent C, Group for the Study of Risperidone in Affective Disorders (GSRAD).
    J Clin Psychiatry; 2001 Oct; 62(10):818-25. PubMed ID: 11816872
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of a new antipsychotic compound (risperidone): results of a pilot study.
    Möller HJ, Pelzer E, Kissling W, Riehl T, Wernicke T.
    Pharmacopsychiatry; 1991 Nov; 24(6):185-9. PubMed ID: 1725925
    [Abstract] [Full Text] [Related]

  • 9. Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome--a functional approach.
    Hillert A, Maier W, Wetzel H, Benkert O.
    Pharmacopsychiatry; 1992 Sep; 25(5):213-7. PubMed ID: 1384075
    [Abstract] [Full Text] [Related]

  • 10. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

  • 11. Using antipsychotic agents in older patients.
    Alexopoulos GS, Streim J, Carpenter D, Docherty JP, Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.
    J Clin Psychiatry; 2004 Dec; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [Abstract] [Full Text] [Related]

  • 12. Obsessive compulsive disorder, depression, and fluoxetine.
    Hollander E, Mullen L, DeCaria CM, Skodol A, Schneier FR, Liebowitz MR, Klein DF.
    J Clin Psychiatry; 1991 Oct; 52(10):418-22. PubMed ID: 1938978
    [Abstract] [Full Text] [Related]

  • 13. [Bipolar obsessive-compulsive disorder: confirmation of results of the "ABC-OCD" survey in 2 populations of patient members versus non-members of an association].
    Hantouche EG, Kochman F, Demonfaucon C, Barrot I, Millet B, Lancrenon S, Akiskal HS.
    Encephale; 2002 Oct; 28(1):21-8. PubMed ID: 11963340
    [Abstract] [Full Text] [Related]

  • 14. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH.
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [Abstract] [Full Text] [Related]

  • 15. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.
    Zohar J, Kaplan Z, Benjamin J.
    J Clin Psychiatry; 1993 Oct; 54(10):385-8. PubMed ID: 7903293
    [Abstract] [Full Text] [Related]

  • 16. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.
    Endicott J, Paulsson B, Gustafsson U, Schiöler H, Hassan M.
    J Affect Disord; 2008 Dec; 111(2-3):306-19. PubMed ID: 18774180
    [Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP, Eerdekens E, Berry SA, Eerdekens M.
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [Abstract] [Full Text] [Related]

  • 18. [New chemotherapy approaches to psychoses].
    Olié JP, Baylé FJ.
    Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
    [Abstract] [Full Text] [Related]

  • 19. Reduced short-term obsessive-compulsive symptoms in schizophrenic patients treated with risperidone: a single-blind prospective study.
    Veznedaroglu B, Ercan ES, Kayahan B, Varan A, Bayraktar E.
    Hum Psychopharmacol; 2003 Dec; 18(8):635-40. PubMed ID: 14696023
    [Abstract] [Full Text] [Related]

  • 20. Risperidone in the treatment of mania.
    Tohen M, Zarate CA, Centorrino F, Hegarty JI, Froeschl M, Zarate SB.
    J Clin Psychiatry; 1996 Jun; 57(6):249-53. PubMed ID: 8666562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.